The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effect of hormone therapy on risk of hip and knee joint replacement in the women's health initiative
Abstract
Objective: To determine the effect of hormone therapy on arthroplasty rates. Methods: We examined data from the Women's Health Initiative placebo‐controlled, double‐blind, randomized trials. Community‐dwelling women ages 50–79 years were enrolled at 40 US clinics. Women with prior arthroplasty were excluded, yielding a sample size of 26,321 subjects. Women who had had hysterectomies (n = 10,272) were randomly assigned to receive 0.625 mg/day conjugated equine estrogens (n = 5,076), or placebo (n = 5,196), with a mean followup of 7.1 years. Those who had not had hysterectomies (n = 16,049) were randomly assigned to receive estrogen plus progestin (n = 8,240), given as 0.625 mg/day conjugated equine estrogens plus 2.5 mg/day medroxyprogesterone acetate, or placebo (n = 7,809), with a mean followup of 5.6 years. Participants reported hospitalizations, and arthroplasties were identified by procedure codes. Arthroplasties due to hip fracture were censored. Cox proportional hazards regression was used to assess hazard ratios (HRs) and 95% confidence intervals (95% CIs) using intent‐to‐treat methods and outcome of time to first procedure. Results: In the estrogen‐alone trial, women receiving hormone therapy had significantly lower rates of any arthroplasty (HR 0.84 [95% CI 0.70–1.00], P = 0.05). However, this effect was borderline statistically significant for hip arthroplasty (HR 0.73 [95% CI 0.52–1.03], P = 0.07), and not significant for knee arthroplasty (HR 0.87 [95% CI 0.71–1.07], P = 0.19). In the estrogen‐plus‐progestin trial, there was no association for total arthroplasty (HR 0.99 [95% CI 0.82–1.20], P = 0.92) or for individual hip (HR 1.14 [95% CI 0.83–1.57], P = 0.41) or knee (HR 0.91 [95% CI 0.72–1.15], P = 0.41) arthroplasties. Conclusion: These data suggest that hormone therapy may influence joint health, but this observed decrease in risk may be limited to unopposed estrogen and may possibly be more important in hip than in knee osteoarthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Expression of genes for estrogen receptors α and β in human articular chondrocytes
Ushiyama, T., Ueyama, H., Inoue, K., Ohkubo, I., & Hukuda, S. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1999.0260 · Cited by 195
Cited by
Epidemiology of Osteoarthritis
Zhang, Y., & Jordan, J. M. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.03.001 · Cited by 2,316
Epidemiology and burden of osteoarthritis
Litwic, A., Edwards, M. H., Dennison, E. M., & Cooper, C. (2013) · British Medical Bulletin · doi:10.1093/bmb/lds038 · Cited by 1,315
Long, H., Liu, Q., Yin, H., Wang, K., Diao, N., Zhang, Y., Lin, J., & Guo, A. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42089 · Cited by 1,155
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Metadata
- Authors
- Cirillo, D. J., Wallace, R. B., Wu, L., & Yood, R. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-09-28
- Volume
- 54
- Issue
- 10
- Pages
- 3194-3204
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2088306158
- Cited by
- 167
- References
- 2
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of hormone therapy on risk of hip and knee joint replacement in the women's health initiative. https://app.cochat.ai/papers/10.1002/art.22138
- The paper
- Cirillo, D. J., Wallace, R. B., Wu, L., & Yood, R. A. (2006). Effect of hormone therapy on risk of hip and knee joint replacement in the women's health initiative. Arthritis & Rheumatism. https://doi.org/10.1002/art.22138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.